title: The new biologics in pregnancy.
abstract: Growing numbers of women of reproductive age are prescribed new biological agents. This is resulting in more pregnancies exposed to these drugs. What are the new biologics (also referred to as biologicals) and what are their indications? How are they currently used in pregnant women? What are the concerns when treating pregnant women with biologics? What do we know about the reproductive safety of these agents? Current and future research is discussed.
authors.forename: Anna
authors.initials: A
authors.lastname: Pupco
mesh_terms: D000014:Abnormalities, Drug-Induced / Q000097:blood / Q000175:diagnosis / Q000209:etiology* / Q000517:prevention & control; D001688:Biological Products / Q000009:adverse effects* / Q000097:blood / Q000493:pharmacokinetics; D005260:Female; D005865:Gestational Age; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D011248:Pregnancy Complications / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D011297:Prenatal Exposure Delayed Effects; D018570:Risk Assessment; D012307:Risk Factors; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D001688:Biological Products; D014409:Tumor Necrosis Factor-alpha